- Jegede Olushola Olakunle1, Okorochi Chinenye Mary2*, Ekuma Moses Ikenna3, Uzoigwe Joseph Chukwuma4. Edegbe Felix Osogu5, Kelechi Chikezie6, Aminu Zakari Mohammed7, Martin Anazodo Nnoli8
- DOI: 10.5281/zenodo.18358635
- SSR Journal of Medical Sciences (SSRJMS)
Background: High-grade prostatic
intraepithelial neoplasia (HGPIN) represents the most likely precursor lesion
to prostatic adenocarcinoma. Understanding its prevalence, age distribution,
and association with other prostatic lesions is crucial for prostate cancer
risk stratification and surveillance protocols in African populations where
data remain limited.
Objective: This study aimed to
determine the prevalence of HGPIN in prostatic biopsies at Jos University
Teaching Hospital (JUTH), characterize the age-specific distribution, evaluate
associated lesions, and assess temporal trends over a ten-year period.
Methods: A retrospective analysis
was conducted on 1,450 prostatic specimens received at JUTH histopathology
department from January 2000 to December 2009. All cases diagnosed with HGPIN
were identified and analyzed for age distribution, associated prostatic lesions
(nodular hyperplasia, chronic prostatitis, and carcinoma), histomorphologic
patterns, and temporal trends. Statistical analysis included descriptive
statistics and chi-square tests
Results: HGPIN was diagnosed in 41
of 1,450 prostatic specimens, yielding a prevalence of 2.8%. Patient ages
ranged from 50 to ≥100 years with a mean age of 72.8 years and peak incidence
in the 8th decade (70-79 years, 39.0%). The age-specific prevalence increased
progressively with advancing age. Isolated HGPIN accounted for 34.1% (n=14) of
cases, while 65.9% (n=27) occurred in association with other lesions: nodular
hyperplasia (53.7%, n=22), chronic prostatitis (7.3%, n=3), and concurrent
adenocarcinoma (4.9%, n=2). Annual HGPIN detection showed an increasing trend
from 2000-2008, with peak detection in 2008 (12 cases), followed by a decline
in 2009 (6 cases). The mean age for HGPIN patients (72.8 years) was comparable
to that of prostatic adenocarcinoma patients, suggesting similar age-related
oncogenic processes.
Conclusion: HGPIN prevalence of 2.8% in this North Central Nigerian population falls within the reported range for African populations. The peak occurrence in the 8th decade, frequent association with nodular hyperplasia (53.7%), and occasional concurrence with adenocarcinoma (4.9%) underscore the importance of careful histopathological evaluation and appropriate clinical follow-up. The increasing temporal trend suggests improved diagnostic awareness. These findings support the need for enhanced prostate cancer screening and surveillance protocols in Nigerian men, particularly those aged 60 years and above.

